These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 21824186)

  • 1. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
    Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
    Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.
    Soulimane S; Simon D; Shaw J; Witte D; Zimmet P; Vol S; Borch-Johnsen K; Magliano D; Vistisen D; Balkau B
    Diabetes Res Clin Pract; 2012 Jun; 96(3):392-9. PubMed ID: 21741107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
    Borg R; Vistisen D; Witte DR; Borch-Johnsen K
    Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
    Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
    Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
    Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
    Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the same clinical risk factors relevant for incident diabetes defined by treatment, fasting plasma glucose, and HbA1c?
    Balkau B; Soulimane S; Lange C; Gautier A; Tichet J; Vol S;
    Diabetes Care; 2011 Apr; 34(4):957-9. PubMed ID: 21346181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
    Bernal-Lopez MR; Santamaría-Fernandez S; Lopez-Carmona D; Tinahones FJ; Mancera-Romero J; Peña-Jimenez D; Jansen-Chaparro S; Baca-Osorio AJ; Cuesta-Muñoz AL; Serrano-Rios M; Gomez-Huelgas R
    Diabet Med; 2011 Nov; 28(11):1319-22. PubMed ID: 21966956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.
    Wang W; Lee ET; Howard BV; Fabsitz RR; Devereux RB; Welty TK
    Diabetes Care; 2011 Feb; 34(2):363-8. PubMed ID: 21270194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and baseline metabolic factors for incident diabetes and HbA(1c) at follow-up: the healthy twin study.
    Sung J; Lee K; Song YM; Lee M; Kim J
    Diabetes Metab Res Rev; 2015 May; 31(4):376-84. PubMed ID: 25400114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
    Inoue K; Matsumoto M; Akimoto K
    Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
    Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
    Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
    Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
    Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnicity modifies the relation between fasting plasma glucose and HbA1c in Indians, Malays and Chinese.
    Venkataraman K; Kao SL; Thai AC; Salim A; Lee JJ; Heng D; Tai ES; Khoo EY
    Diabet Med; 2012 Jul; 29(7):911-7. PubMed ID: 22283416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
    Droumaguet C; Balkau B; Simon D; Caces E; Tichet J; Charles MA; Eschwege E;
    Diabetes Care; 2006 Jul; 29(7):1619-25. PubMed ID: 16801588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.